PRESS RELEASE

CLOSING OF THE SALE OF FLUINDAPYR

TO FMC CORPORATION FOR 55 EURO MILLION

Milan, October 2nd, 2020 - Isagro S.p.A., following the communications of May 6th and July 24th, announces to have finalized today the Closing of the sale of the molecule Fluindapyr to the North American company FMC Corporation and to have cashed-in the related Price, equal to 55 Euro million.

The sale of Fluindapyr is part of the process of redefinition of Isagro's business model, involving a refocusing in the biosolutions and copper-based products, keeping in portfolio selected organic chemicals based on a rationale of integrated crop management. The 55 Euro million cashed-in from the sale - which, together with the around 50 Euro million cashed-in from the sale of Isagro Asia of last 27th December, led to a consolidated net financial position at credit - will be utilized to finance the growth projects of the Group, also through acquisitions.

"This transaction" - said Giorgio Basile, President and CEO of Isagro - "confirms the value of our Research, which will be increasingly focused on the Bio-Copper segment, and creates the financial conditions for the growth of Isagro".

It shall be remembered that Fluindapyr is a broad-spectrum fungicide belonging to the innovative "SDHi" class, discovered by Isagro and co-developed since 2012 with FMC itself. The book value for Isagro as of June 30th, 2020 was around 25 Euro million.

About Isagro

Isagro S.p.A., an independent company born in 1993 with Montecatini/Montedison origin, is listed on the Milan Stock Exchange since 2003. Initially based on the discovery and development of new chemical molecules, the last one being Fluindapyr, the Company leads today a Group offering agricultural solutions at low environmental impact, with a growth project focused on Copper-based products and Biosolutions as part of its new business model aimed also at capitalizing on the current product portfolio qualified for an integrated crop management.

In 2014 Isagro issued Growth Shares, an innovative category of special shares specifically conceived for companies having a Controlling Subject. Main characteristics of Growth Shares are the absence of voting rights, an extra-dividend vs. Ordinary Shares (20% in the case of Isagro) and the automatic conversion into Ordinary Shares in the ratio 1:1 in any case of loss of controlling stake by the Controlling Subject and/or of Compulsory Public Offer.

For more information:

Ruggero Gambini

Erjola Alushaj

Chief Financial Officer

Group Financial Planning &

Tel. +39(0)240901.280

Coordination and IR Manager

Tel. +39(0)240901.340

www.isagro.comir@isagro.com

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Isagro S.p.A. published this content on 02 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 October 2020 12:29:06 UTC